Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT04507412

Intravenous Dexamethasone Administration in Patients Undergoing Total Shoulder Arthroplasty

Conditions: Arthroplasty, Replacement, Shoulder

Sex: All

Ages: 58 Years – 85 Years

Healthy volunteers: No

Phase: PHASE4

Enrollment: 74

Sponsor: Christian Candrian

Location: Christian Candrian Lugano

Summary

The aim of the study is to evaluate if intravenous steroid supplementation can provide advantages over routine analgesia protocols in terms of post-operative symptoms (pain and nausea), length of hospital stay, shoulder range of motion, function and patient satisfaction

Eligibility Criteria

Inclusion Criteria: * Patients undergoing unilateral primary total anatomical or reverse shoulder arthroplasty (Total Shoulder Arthroplasty) * Patients with a BMI \>18.5 and \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04507412). StuddyBuddy aggregates publicly available trial information.